Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled budesonide for prevention of acute mountain sickness
ChiCTR-PRC-12002748Phase 4Completed
- Sponsor
- Institute of Cardiovascular Diseases, Xinqiao Hospital
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide in acute mountain sickness (AMS) (4 arms), sponsored by Institute of Cardiovascular Diseases, Xinqiao Hospital. Primary endpoints: Lake Louise Score and Oxygen saturation. Started Jun 2012; status: completed.
02
Drugs
budesonide
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on ChiCTR-PRC-12002748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-12002748.